PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-97.35%
Negative net income growth while ORCL stands at 46.71%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
16.77%
D&A growth well above ORCL's 4.74%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-592.24%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
1.99%
Less working capital growth vs. ORCL's 31.34%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.99%
Lower 'other working capital' growth vs. ORCL's 31.34%. David Dodd would see fewer unexpected short-term demands on cash.
11744.12%
Well above ORCL's 214.09%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-10.84%
Negative yoy CFO while ORCL is 42.38%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-21.97%
Both yoy lines negative, with ORCL at -54.04%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
30.27%
Some yoy expansion while ORCL is negative at -5.95%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-31.91%
We reduce yoy sales while ORCL is 28.34%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
9.74%
Investing outflow well above ORCL's 12.89%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
32.24%
Issuance growth of 32.24% while ORCL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-106.83%
Both yoy lines negative, with ORCL at -62.16%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.